Invention Grant
- Patent Title: CD44v6-derived peptides for treating metastasizing cancer
- Patent Title (中): 用于治疗转移性癌症的CD44v6衍生肽
-
Application No.: US14407283Application Date: 2013-11-21
-
Publication No.: US09593146B2Publication Date: 2017-03-14
- Inventor: Veronique Orian-Rousseau , Alexandra Matzke , Helmut Ponta
- Applicant: AMCURE GMBH
- Applicant Address: DE Eggenstein-Leopoldshafen
- Assignee: AMCURE GMBH
- Current Assignee: AMCURE GMBH
- Current Assignee Address: DE Eggenstein-Leopoldshafen
- Agency: Leason Ellis LLP
- Priority: GB1220889.8 20121121
- International Application: PCT/EP2013/074404 WO 20131121
- International Announcement: WO2014/079943 WO 20140530
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61P35/00 ; C07K7/06 ; C07K7/08 ; A61K38/00
Abstract:
The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of pancreatic cancer.
Public/Granted literature
- US20150183826A1 CD44V6-Derived Peptides for Treating Metastasizing Cancer Public/Granted day:2015-07-02
Information query
IPC分类:
